Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin in Japanese Encephalitis
NCT00216268Phase 2Unknown
- Sponsor
- Indian Council of Medical Research
- Start
- Jul 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Japanese encephalitis (JE) comparing Ribavirin with Placebo (2 arms). Primary endpoint: Mortality during hospital stay. Status: unknown.
02
Drugs
ribavirin
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT00216268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216268.